Abbott Laboratories: Disclosure Regarding Horseshoe Crab-Derived Endotoxin Testing

BE IT RESOLVED: Shareholders request that Abbott Laboratories issue a report, at reasonable expense and omitting proprietary information, analyzing the supply chain risks of horseshoe crab materials and whether synthetic endotoxin testing alternatives would reduce material risk to the Company.

BiodiversityAs You SowNovember 6, 2025Biodiversity, biodiversity, biodiversity loss, horseshoe crabs, pharmaceutical, Pharmaceutical, Biomedicalbiomedical, keystone, Keystone, keystone species